January 22, 2018

Paid Study for Afib Patients Who Have Had Both Kinds of Cardioversion

Paid Study for Atrial Fibrillation Patients Who Have Had Both Chemical and Electrical Cardioversion

Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation – Video

At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial […]

Women, Atrial Fibrillation, and Inflammation

Since I posted a few days ago on Statins Help Women with Atrial Fibrillation, Hans Larsen, owner of the Lone Atrial Fibrillation Bulletin Board, created a great recap of studies related to inflammation and atrial fibrillation, including lone atrial fibrillation (afib without any underlying heart disease). It’s definitely worth checking out to find out more about inflammation. Some findings he included […]